Thalidomide and dexamethasone combination for refractory multiple myeloma
Open Access
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier BV in Annals Of Oncology
- Vol. 12 (7), 991-995
- https://doi.org/10.1023/a:1011132808904
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyBlood, 2000
- Thalidomide in patients with advanced multiple myelomaThe Hematology Journal, 2000
- Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myelomaBritish Journal of Haematology, 2000
- Thalidomide for resistant and relapsing myelomaSeminars in Hematology, 2000
- Thalidomide — A Revival StoryNew England Journal of Medicine, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1983
- Reporting results of cancer treatmentCancer, 1981